Satellos Bioscience's total assets for Q1 2026 were C$75.28M, an increase of 136.50% from the previous quarter. TSE:MSCL total liabilities were C$4.57M for the fiscal quarter, a 11.44% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.